Home›Companies›Healthcare›Procyrion

Procyrion, Inc.

Updated Oct 27, 2026·Latest SEC filing Feb 5, 2024·Suggest an edit

About Procyrion

Procyrion is a private company based in Houston, Texas, incorporated in 2019 in Delaware. It has reported $109,471,601 raised in six offerings on Form D since February 2012. Its chief executive is Eric Fain.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 13, 2023Feb 5, 2024$57,670,605of $64.0M target24$2.4MEquity, OptionsRule 506(b)Form D ↗
Jun 25, 2019Jul 8, 2019$29,999,996fully sold12$2.4MEquityRule 506(b)Form D ↗
Jan 23, 2018Jan 31, 2018$16,000,000fully sold4$4.0MEquityRule 506(b)Form D ↗
Jun 26, 2015Jul 13, 2015$5,151,000of $10.0M target16$321KEquityRule 506(b)Form D ↗
Nov 19, 2014Dec 3, 2014$650,000fully sold9$72,222EquityRule 504, Rule 506(b)Form D ↗
Not yetFeb 2, 2012$0of $2.5M target0—Equity06Form D ↗
Total, six offerings$109,471,601

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Procyrion's Form D filed Feb 5, 2024.

JB
Jeff Bird
Director
MC
Marc Chaput
Director
JH
Jason Heuring
Executive officer
GB
EF
Eric Fain
President and CEO, director
JM
J. Meyer
Director

Earlier filings also listed Benjamin Hertzog (president and director, last listed Jan 2018), Stephen Oldham (director, last listed Jul 2015), Reynolds, III Delagado (director, last listed Jul 2015), Reynolds Delgado III (director, last listed Dec 2014), Bryan Nearn (vice president, last listed Feb 2012) and Brian Oliver (president of sole, last listed Feb 2012).

Sources

  1. SECProcyrion, Inc. filing history